MedPath

Examining a Text Message Intervention for Smoking Cessation

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Nicotine Dependence
Interventions
Behavioral: text messaging for smoking cessation
Behavioral: Generic text messages
Registration Number
NCT01166464
Lead Sponsor
The Miriam Hospital
Brief Summary

The primary goal of this study is to use qualitative interviews and focus groups to aid us in adapting a face-to-face smoking cessation intervention for delivery through text messaging. After design is completed, the intervention will be pilot tested with a sample of young adults (ages 18-35) who smoke. Final assessments will be conducted at 7 weeks (end of treatment) and both 3 and 6 month follow up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Age 18 to 35
  • Current daily smoker
  • Has a cell phone with text messaging capability
  • Uses text messaging at least once monthly
  • Interested in quitting smoking
  • Willing to set a quit date within the next 30 days
  • Has access to a physician
Exclusion Criteria
  • Does not read and speak English with adequate comprehension
  • Is currently participating in a smoking cessation program
  • Concurrent drug/alcohol abuse
  • Mental health issues that would interfere with study compliance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Text Messagingtext messaging for smoking cessationA text message-based intervention for smoking cessation
ControlGeneric text messagesIndividuals in this group will receive generic (non-smoking related) text messages on the same schedule as the intervention arm. This provides a control for staff/program contact time and participant burden.
Primary Outcome Measures
NameTimeMethod
Smoking abstinenceSix months post-treatment

7-day point prevalence abstinence will be measured at 6 months post-treatment.

Secondary Outcome Measures
NameTimeMethod
Usability and Acceptability of the intervention7 weeks (end of treatment)

Usability and acceptability of the intervention will be assessed at the end of treatment (week 7).

Trial Locations

Locations (1)

The Miriam Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath